Join Our Team
We are driven to bring hope and life-changing therapies to patients and families.
The values that are highest priority to us are patient-focus, integrity, people, excellence and impact.
We understand that the best work is performed by those who are happy on the job. We foster an environment that is supportive, hard-working and fun.
At Catabasis, we’re working together to make a difference in patients' lives by discovering and developing life-changing therapies for patients. We recognize that the success of our business depends on the excellence of our people. With this in mind, we are focused on building a team of highly-motivated and skilled individuals through our investment in recruitment, training and development of our employees.
If you are interested in exploring employment opportunities at Catabasis, please send your cover letter and resume to firstname.lastname@example.org.
Catabasis is proud to be an Equal Opportunity Employer.
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) is a clinical-stage biopharmaceutical company focused on bringing transformative therapies to patients with rare diseases. Our corporate focus is to discover, develop and commercialize transformative therapies for rare diseases. Our SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART linker platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates. Our two clinical programs, CAT-1004 and CAT-2054, have the potential to disrupt treatment paradigms. CAT-1004 is an oral small molecule NF-kB inhibitor that has the potential to be a disease-modifying therapy for all patients affected with Duchenne muscular dystrophy (DMD), regardless of the underlying mutation. CAT-2054 is an oral small molecule Sterol Regulatory Element-Binding Protein (SREBP) inhibitor being developed for serious lipid disorders such as nonalcoholic steatohepatitis. Catabasis is building a team of highly motivated and experienced professionals who are committed to achieving its mission of bringing hope and life-changing therapies to patients.
Reporting to the Senior Director, Finance and Controller, the Manager, SEC Reporting will be responsible for the preparation of Securities and Exchange Commission (SEC) filings (8Ks, 10Qs, 10Ks) and supporting other accounting and reporting activities including share-based compensation and equity transactions. The position requires a high-energy, results-oriented professional with strong technical accounting skills, responsible for producing high-quality financial reporting in a fast-growing public company environment. The qualified candidate will join a very small finance team and have excellent opportunities to learn and develop new skills as the Company grows. The position provides an attractive compensation package including base salary, potential bonus, an equity incentive plan and exceptional benefits.